Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Clinical trial NCT05126901 · COMPLETED
Trial details
- NCT number
- NCT05126901
- Sponsor
- Shield Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2024-06-09
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.